Key Takeaways
- Shares of UnitedHealth declined more than 5% during Monday’s premarket session following Berkshire Hathaway’s revelation that it completely divested its approximately 5 million-share holding
- The divestment occurred during a comprehensive portfolio restructuring led by Greg Abel, Berkshire’s new chief executive who assumed leadership from Warren Buffett on January 1st
- Additional headwinds for UNH include a federal government freeze on new Medicare enrollments affecting home healthcare providers
- Management announced intentions to reduce its Medicare Advantage membership by 1.3 million to safeguard profitability amid escalating medical expenses
- On a positive note, UNH exceeded first-quarter earnings projections and elevated its annual profit forecast in its most recent financial disclosure
Shares of UnitedHealth (UNH) tumbled over 5% during Monday’s premarket session, trading near $380.35, following Berkshire Hathaway’s disclosure that it liquidated its entire position in the healthcare giant.
UnitedHealth Group Incorporated, UNH
According to Berkshire’s most recent 13F regulatory filing, which reflects portfolio holdings through March 31st, the investment conglomerate eliminated its complete stake of roughly 5 million shares in UNH. The exit stands out particularly because Berkshire initially established the position just in Q2 2025 — holding the stock for less than twelve months.
This divestment represents one element of a comprehensive portfolio realignment being executed by Greg Abel, who formally assumed the role of CEO at Berkshire on January 1st following Warren Buffett’s transition.
When Berkshire exits a position this rapidly, market participants pay attention. Traders interpreted the move as a concerning signal, triggering immediate selling momentum.
UNH wasn’t Berkshire’s only complete exit. The conglomerate simultaneously closed out holdings in Amazon, Domino’s, Pool Corp, Mastercard, and Visa throughout the first quarter. Most of these stocks experienced modest declines in Monday’s early session.
Meanwhile, Berkshire initiated positions in Delta Air Lines and Macy’s, while expanding its holdings in Alphabet and the New York Times.
Medicare Challenges and Member Reductions Intensify Concerns
The stock faces pressures beyond Berkshire‘s divestment. UNH is contending with a federal moratorium blocking new Medicare enrollments for home healthcare providers, introducing additional regulatory complications.
Compounding matters, management disclosed plans to eliminate 1.3 million Medicare Advantage members. This strategic decision aims to preserve profit margins while navigating continuously rising medical expenditures.
This confluence of factors — a prominent institutional investor liquidating its stake, regulatory obstacles, and membership contraction — has prompted market participants to recalibrate their short-term expectations for the healthcare stock.
Justice Department Investigation Remains an Overhang
UNH continues facing Department of Justice examination regarding its billing methodologies. This ongoing investigation remains a persistent concern.
The stock has declined approximately 20% year-to-date entering this week, with Monday’s movement adding another difficult chapter to an already challenging period for the managed-care leader.
However, some positive developments exist. UnitedHealth’s first-quarter financial results demonstrated operational resilience.
The company surpassed Q1 earnings expectations and upgraded its full-year profit guidance, providing temporary reassurance to investors before Monday’s selloff materialized.
Technical indicators currently generate a Buy signal for UNH, with average daily volume measuring approximately 8.49 million shares. The company’s market capitalization stands at roughly $357.7 billion.
Presently, the stock is processing the impact of Berkshire’s departure alongside broader Medicare cost pressures and enrollment policy modifications.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
